HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,775 | +5.9% | 6,303 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $227,349 | -13.2% | 6,303 | -8.1% | 0.01% | -27.3% |
| Q1 2023 | $262,060 | -32.9% | 6,862 | 0.0% | 0.01% | -73.2% |
| Q4 2022 | $390,448 | +35.6% | 6,862 | -5.7% | 0.04% | +192.9% |
| Q3 2022 | $288,000 | -10.0% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $320,000 | +10.3% | 7,274 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $290,000 | -0.7% | 7,274 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $292,000 | -1.4% | 7,274 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $296,000 | -10.3% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $330,000 | +8.9% | 7,274 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $303,000 | -2.6% | 7,274 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $311,000 | – | 7,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |